|
Market Closed -
Nasdaq
07:00:00 29/10/26 am AEDT
|
5-day change | 1st Jan Change | ||
| 57.29 USD | +28.25% |
|
+44.78% | +86.01% |
| 06:48pm | SEB raises price target for Genmab to DKK 4,600 (3,175), reiterates buy | FW |
| 06:06pm | Jyske Bank cuts Genmab to sell (hold), price target DKK 3,725 - BN | FW |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Bio Therapeutic Drugs
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 64.14B | |||||
| 55.53B | |||||
| 53.03B | |||||
| 45.99B | |||||
| 42.45B |
- Stock Market
- Stocks
- GMAB Stock
- GMAB Stock
- Charts Genmab A/S
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
